Rate My Professor Rosemary Hollick

Dr Hollick's research interests centre on enhancing the design, delivery, and experience of health and care services for individuals with rheumatic and musculoskeletal diseases. She employs applied mixed-methods research, combining routine health data, qualitative methods, epidemiology, and patient partnerships to tackle issues in diagnosis, access, and long-term management, with particular emphasis on rare autoimmune rheumatic diseases, fibromyalgia, and rural health disparities. Over the past seven years, she has obtained more than £9 million in research funding. Her contributions have earned recognition through awards such as the NIHR Innovation and Inclusion Award in 2022 for patient partner involvement in the VOICES study and a place in Arthritis UK's Top 10 Research Highlights of 2024 for the same project. Selected key publications include 'A meta-analysis of smoking and fracture risk to update the FRAX® tool' (2026, Osteoporosis International), 'Patterns of Healthcare Use, Comorbidities, and Treatment of Fibromyalgia: Insights from Survey and Administrative Healthcare Data in Scotland and Wales' (2025, PACFiND), and 'Healthcare use in individuals with rheumatoid arthritis during the COVID-19 pandemic and beyond: A cohort study in three nations of the UK' (2025, Rheumatology). Additionally, she influences the field through roles including Associate Editor of Rheumatology (Oxford) since 2022, Deputy Chair of the British Society for Rheumatology Heberden Committee (2021-2025), steering committee member of the UK and Ireland Vasculitis Society, member of the Scotland Rare Disease Implementation Board since 2023, and member of the Scottish Parliament Cross Party Group on Arthritis and Musculoskeletal Conditions since 2020.